Comparative Study of Immunofluorescent Antinuclear Antibody Test and Line Immunoassay Detecting 15 Specific Autoantibodies in Patients With Systemic Rheumatic Disease

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 4, 2012, Pages 307-314

  Lee, Sun Ah ^a   Kahng, Jimin ^a   Kim, Yonggoo ^a   Park, Yeon Joon ^a   Han, Kyungja ^a   Kwok, Seung Ki ^a   Park, Sung hwan ^a   Oh, Eun Jee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Antinuclear antibodies; Immunofluorescence; Line immunoassay; Systemic rheumatic disease; Test comparisons

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE PROTEIN B; DOUBLE STRANDED DNA ANTIBODY; HISTONE; JO 1 ANTIBODY; LA ANTIBODY; PCNA ANTIBODY; PM SCL ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RIBOSOME PROTEIN; RO ANTIBODY; RO52 ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; LINE IMMUNOASSAY TEST; MAJOR CLINICAL STUDY; NUCLEOSOME; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, ANTINUCLEAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOASSAY; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY;

ANAS;

EID: 84863998888     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21522     Document Type: Article

References (21)

1. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger Ha. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71-81.
2. Tozzoli R, Bizzaro N, Tonutti E, et al. Italian society of laboratory medicine study group on the diagnosis of autoimmune diseases: Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002;117:316-324.
3. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60:1131-1136.
4. Malleson PN, Sailer M, Mackinnon MJ. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child 1997;77:299-304.
5. Bonaguri C, Melegari A, Dall'Aglio P, et al. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing. Ann NY Acad Sci 2009;1173:124-129.
6. Almeida González D, Cabrera de León A, Rodríguez Pérez Mdel C, et al. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. J Immunol Methods 2010;360:89-95.
7. Van Praet JT, Vander Cruyssen B, Bonroy C, Smith V, Delanghe J, De Keyser F. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies. Clin Exp Rheumatol 2009;27:971-976.
8. Parker JC, Bunn CC. Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies. J Clin Pathol 2011;64:631-633.
9. Bizzaro N, Wiik A. Appropriateness in anti-nuclear antibody testing: From clinical request to strategic laboratory practice. Clin Exp Rheumatol 2004;22:349-355.
10. Kang SY, Lee WI. Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method. Korean J Lab Med 2009;29:145-151.
11. Kang I, Siperstein R, Quan T, Breitenstein ML. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies. Clin Rheumatol 2004;23:509-515.
12. Ménard HA. Antinuclear antibodies: The medium is the message. Clin Exp Rheumatol 2000;18:429-430.
13. Muro Y. Antinuclear antibodies. Autoimmunity 2005;38:3-9.
14. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade Le. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 2011;63:191-200.
15. Tampoia M, Brescia V, Fontana A, Zucano A, Morrone LF, Pansini N. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease. Arch Pathol Lab Med 2007;131:112-116.
16. Parker JC, Burlingame RW, Bunn CC. Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis. J Autoimmune Dis 2009;6:2.
17. Bonfa E, Elkon KB. Clinical and serologic associations of the antiribosomal P protein antibody. Arthritis Rheum 1986;29:981-985.
18. Fritzler MJ, McCarty GA, Ryan JP, Kinsella TD. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen. Arthritis Rheum 1983;26:140-145.
19. Hoffman IE, Peene I, Veys EM, De Keyser F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 2002;48:2171-2176.
20. Yang JY, Oh EJ, Kim Y, Park Yj. Evaluation of anti-dsDNA antibody tests: Crithidia luciliae immunofluorescence test, immunoblot, enzyme-linked immunosorbent assay, chemiluminescence immunoassay. Korean J Lab Med 2010;30:675-684.
21. Kim JM, Ihm CH, Sin DH, Ihm MK, Sim Sc. Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases. Korean J Lab Med 2008;28:353-361.